Dillon W C, Hadian D, Ritchie M E
Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis 46202, USA.
Angiology. 2001 Feb;52(2):137-41. doi: 10.1177/000331970105200208.
No-reflow is an unpredictable complication following percutaneous coronary intervention. No-reflow is associated with myocardial ischemia and infarction and increased mortality. A case of refractory no-reflow is described that was rapidly and successfully treated with multiple infusions of high doses of verapamil and adenosine applied directly at the site of no-reflow through a perfusion catheter.
无复流是经皮冠状动脉介入治疗后一种不可预测的并发症。无复流与心肌缺血、梗死及死亡率增加相关。本文描述了一例难治性无复流病例，通过灌注导管在无复流部位直接多次输注高剂量维拉帕米和腺苷，迅速且成功地进行了治疗。
